Bayer seeks approval of $2 billion plan to limit Roundup claims

(Reuters) - Bayer AG (DE:BAYGN) on Wednesday will urge a U.S. judge to give preliminary approval to a controversial $2 billion settlement that would create a framework to resolve future claims that its top-selling Roundup weedkiller causes cancer. Bayer (OTC:BAYRY) has committed up to $9.6 billion to resolve existing claims...